Companies/BE/NYXH

NYXOAH SA

Last · Brussels€1.096-0.014 (-1.26%)close · yahoo · 6h ago
Vol 77.6K ≈ 85.0K
Market cap€111.6M101.8M sh
P/E · TTM-0.5fwd -2.3 · eps -2.19 · loss
Beta1.00vs S&P 500
Div yield0.00%annual · TTM
52w range
€1.07€5.40
Volume77.6Ksession

Issuer

Legal nameNYXOAH SA
HQBelgium (BE)
ListingBE NYXH
ISINBE0974358906
SectorHealthcare
IndustryAdvanced Medical Equipment & Technology
CurrencyEUR
Entity registrylei:5493002O1ESKZ18OXR80
Org IDNYXH
Employees154
AddressNyxoah SA Rue Edouard Belin 12 1435, Mont-Saint-Guibert +32 1 045 90 75
Headline financial metrics
Revenue€4.3M
Operating income€-45.1M
Net income€-43.2M
Free cash flow€-47.3M
Operating margin-1037.3%
Net margin-993.8%
Return on equity-44.1%
Period2023
Loading chart…

OpenFilings analyst

Our analyst

ANNUAL · 2024-03-21

From latest ANNUAL · 2024-03-21

  • Operating Cf Burn
  • Net Margin Sharply Negative
  • Cash Runway Low
  • Accumulated Deficit High
  • Rd Intensity High

Red flags

  • Operating Cf Burn — Negative operating cash flow
  • Net Margin Sharply Negative — Net margin -993.8%
  • Cash Runway Low — Cash runway ~0.5 years
  • Accumulated Deficit High — Accumulated deficit / equity 164%
  • Rd Intensity High — R&D/Revenue 612.9%

Upcoming earnings

1 event
4:40 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.25
Est. revenue
9.9M

Press & signals

3 of 12 recent
  • GlobeNewswire

    Nyxoah Appoints Liam Kelly as Chief Executive Officer

  • GlobeNewswire

    Nyxoah Announces Chief Financial Officer Transition

  • GlobeNewswire

    Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System

The rest of this company's wire — with summaries and source links — is part of Pro.

See plans

Documents

FormReporting forFiledFlags
—2026-12-31≈0
—2026-12-31≈0
—2026-12-31≈0